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A total of 114 strains of Mycobacterium tuberculosis i olated from sputum samples of 114 patients of
pulmonary tuberculosis in south India, were coded and tested for their in vi ro susceptibility to
tuberactinomycin (Tum) incorporated in Lowenstein-Jensen (LJ) medium. Of these strains, 95 (83.3%)
and 15 (13.2%) were susceptible to Tum at 25 and 50 mg/l respectively. Only 4 (3.5%) strains were
inhibited at 100 mg/l or more. Of the 37 drug sensitive strains, 2 (5.4%) were not susceptible to Tum at
25 mg/l compared to 17 (22.1%) of 77 strains-resistant to one or more of antituberculosis drugs (P
<0.02). The drug susceptibility pattern of the strains revealed that there was no significant association of
resistance between Tum and streptomycin or rifampicin or ethambutol or ethionamide or isoniazid.
However, 15 (53.6%) of 28 kanamycin (K) resistant strains were not susceptible to Tum at 25 mg/l. This
cross resistance between Tum and K was further studied in 24 and 15 K sensitive and resistant strains
respectively, by correlating their proportion resistance at 16 mg/l and it was found to have a significant
positive correlation (r = 0.55; X0.01).
Search for new drugs to evolve effective
regimens for treating patients who show resistance
to various antituberculosis drugs is to be continued
and needs noemphasis. Tuberactinomycin
(synonym: Enviomycin), is an antituberculosis
drug derived from Streptomyces griseoverticillatus
var. tuberacticus1. In Japan, this drug is being
used for re-treating patientsof refractory
pulmonary tuberculosis and in lung diseases
caused by Mycobacterium avium complex2. Turn
has been reported to be less toxic than kanamycin
(K) and capreomycin (Cap)3. However, it is
important to know the differences, if any, in the
susceptibility pattern of local strains to Tum in
view of our earlier finding that south Indian
strains of M. tuberculosis were known to be less
susceptible to thiacetazone, although it was
observed that strains isolated elsewhere were
highly susceptible to this drug4. An investigation
was therefore undertaken to study the susceptibility
pattern of south Indian strains of M. tuberculosis
to Turn.
Material & Methods
Cultures: A total of 114 strains of M. tuberculosis
(37 sensitive to available antituberculosis drugs
and 77 resistant strains) isolated from 114 patients
with pulmonary tuberculosis were investigated.
The sensitive and resistant strains were selected in
the ratio of 1:2. M. tuberculosis H37Rv was
included as control throughout the study. All the
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strains were coded before they were subjected to
drug susceptibility tests.
Drug susceptibility tests : Indirect susceptibility
test was performed with the following prei-
nspissation concentrations of Tum in Lowenstein-
Jensen (LJ) medium; 10, 25, 50 and 100 mg/l. The
test procedures and the determination of minimal
inhibitory concentration (MIC) were carried out
as described by Canetti et al5. The proportions
resistant to Tum and K |at 16 mg/l were
calculated as per the procedures described by
Tripathy et al 6.
The following are the MIC levels indicating
resistance for various drugs - streptomycin (S):
> 32 mg/l; isoniazid (I): > 1 mg/l; rifampicin (R):
> 128 mg/l; K: > 64 mg/l; etambutol (Emb) : > 8
mg/l; ethionamide (Eth): > 114 mg/l.
Fisher’s exact test, Chi square test and Student’s
‘t’ test were used for statistical analysis of the data.
Results
The susceptibility of 114 strains to Turn is
presented in Table I. Of the strains, 95 (83.3%)
were susceptible at 25 mg/l. At 50 mg/l, 110
(96.5%) of the strains were susceptible. Only 4
(3.5%) strains had MIC of 100 mg/l or more.
Of the 37 drug sensitive strains, 2 (5.4%) were
not susceptible to Turn at 25 mg/l compared to 17
(22.1%) of the 77 drug resistant strains and the
difference was significant (P <0.02). The difference
in the susceptibility pattern to Turn at 50 mg/l of
sensitive and resistant strains was not significant
(P=0.2). Drug susceptibility pattern of the 114
strains revealed that there was no association of
resistance between Tum and S or I or R or Emb
o r  E t h  ( d a t a  n o t  p r e s e n t e d ) .  B u t  t h e r e
Table I .  Susceptibility of south Indian strains of M .
tuberculosis to tuberactinomycin
Sensitive strains
Resistant strains
Total
MIC of Tum Total
10 25 50 > 100
4 31 2 0 37
7 53 13 4 77
11 84 15 4 114
Table II. Tuberactinomycin susceptibility of M. tuberculosis
as against kanamycin
MIC of Tum MIC of K Total
8 16 32 > 64
10 2 1 6 2 11
25 4 34 28 13 79
50 0 1 4 10 15
> 100 0 0 1 3 4
Total 6 36 39 28 109*
*For 5 strains, K results were not available
was a considerable cross resistance between Tum
and K as 15 (53.6%) of 28 K resistant strains-were
not susceptible to Tum at 25 mg/l (Table II). This
was further studied in 24 and 15 K sensitive and
resistant strains respectively, by correlating their
proportion resistance (Table III) at 16 mg/l and it
was found to ‘have a signif icant posit ive
correlation (r=0.55; P<0.01).
The results of the tests to assess the repro-
ducibility of the MIC values showed that, of the
53 strains investigated, 38 (71.7%) gave the same
MIC in the repeat test. The reproducibility of
MIC 125 mg/l was found to be 79 per cent (with
95% confidence limits of 61 to 91%) and with
MIC > 50 mg/l it was 75 per cent (with 95%
confidence limits of 51 to 91%). All the 3 strains
with MIC > 100 mg/l, when retested, showed the
same MIC. The standard reference strain M .
tuberculosis H37Rv consistently showed MIC
125 mg/l on each of 15 occasions tested.
Discussion
In the present study, 95 (83.3%) of 114 selected
strains of M. tuberculosis obtained from south
Indian patients of pulmonary tuberculosis were
susceptible to Tum at 25 mg/l of LJ medium as
measured by the indirect susceptibility test.
Toyohara7 reported from Japan that 84 per cent
of 197 strains were susceptible to Tum at 25 mg/l
in Ogawa egg medium. From Korea, Gill Han Bai
and Sang Jae Kim8 tested 333 pretreatment
isolates of M. tuberculosis and found that 98 per
cent of them were susceptible at 25 mg/l and the
remaining 2 per cent at 50 mg/l of LJ medium.
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Table III. Frequency distribution of M.tuberculosis strains according to proportion resistant to Tum and K at 16 mg/l
Proportion resistant (%) to Total
KAN TUM
<1.0 1- 5- 10- 15- 25- 50- NA*
<1.0 8 9 – 1 – 1 19
1- 1 1 – 2
5- – 2 1 – 1 4
1O- - 1 1 – 1 – 3
15- 1 1 – 2
25- 1 1 – 1 3 6
50- – 1 – – – 2
NA – 1 – – – 1
Total II 15 3 1 2 4 2 1 39
* results not available
The standard definition of proportion resistance
(1% resistant population at a given concentration)
could not be adopted to classify strains into
sensitive and resistant as the concentration of
Tum (16 mg/l) selected was found to be low and
not suitable for the purpose. Proportion resistance
pattern at higher concentration of Tum would
perhaps have yielded meaningful classification.
The MIC of Tum against M. tuberculosis
H37Rv and 4 clinical isolates, was estimated in
7H9 liquid medium, Sauton’s agar and Middle-
brook’s 7H11 agar medium and found to be 5.0
mg/l or less. Gill Han Bai and Sang Jae Kims also
reported MIC of 4 and 5 mg/l respectively using
Kirchner’s medium with 10 per cent horse serum
and in Dubos medium.
M. tuberculosis H37Rv and 83.3 per cent of the
clinical isolates were inhibited by Tum at 25 mg/l
in LJ medium. The higher level of concentration
for inhibition by aminoglycosides such as Cap, K,
lividomycin, viomycin and Tum, is probably due
to binding of a major part of the drug to protein
in egg based media9.
The present in vitro susceptibility studies of
south Indian strains of M. tuberculosis ndicate
that there is very little cross resistance between
Tum and other drugs with the exception of K.
These findings could form the-basis for further
studies.
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